Sabitlenmiş Tweet
Happiness is an empty beach, the wind in your ears, your best friend by your side, and 0/8 feet on the ground
English
Ian Davis (Bluesky @profiand)
10.9K posts
Ian Davis (Bluesky @profiand)
@Prof_IanD
Professor of medicine | medical oncologist | Head @EHCSMonash | Chair, @ANZUPtrials | husband, father, grandfather, blessed | want to make a positive difference
Naarm, Wurundjeri land Katılım Haziran 2016
619 Takip Edilen3K Takipçiler
Ian Davis (Bluesky @profiand) retweetledi
Attending #ASCO26 ? We have some tips for you to make the most of this event. Both first-timers and veterans will find these useful. oncologybg.com/2026/05/22/are….
English
@oncology_bg Congratulations Professor Gyawali, and very well deserved!
English
Well, I have some news to share. 😊
Very grateful and honoured to my institution and Department for recognizing my contributions through this promotion. It really means a lot.
Incredibly thankful and grateful to everyone who has contributed to this journey- my mentors, teachers, students, mentees, colleagues, friends, and patients spanning 4 different countries. Also the funders of my research (OICR, MOHCCN) and organizations like WHO/ASCO/ESMO who opened up doors for me.
But most of all, to my family, whose love and sacrifices are the reason I am here today.
English
Advanced Prostate Cancer Consensus Conference@APCCC_Lugano
Assessment of the ability of Decipher Prostate Genomic Classifier (DGC) >0.85 to identify patients who benefit from adding docetaxel (DOC) to androgen deprivation therapy (ADT) plus enzalutamide (ENZ): Level 1B evidence from the ENZAMET study. #ASCO25 Abstract asco.org/abstracts-pres… This ENZAMET biomarker 🎯analysis evaluated whether Decipher Genomic Classifier (DGC) scores predict benefit from adding docetaxel💊 (DOC) to androgen deprivation therapy (ADT) plus enzalutamide (ENZ) in metastatic hormone-sensitive prostate cancer. Among 634 patients, high DGC scores (>0.85) were associated with worse overall survival on ADT plus ENZ alone, but this adverse prognosis was negated by adding DOC. Findings suggest DGC may identify patients most likely to benefit from triplet therapy, particularly in high-volume disease. @ChrisSweens1 @ChrisSweens1 @MartinStockler @anis_a_hamid @AzadOncology @Davicioni @AttardLab @Prof_IanD @OncoAlert 🚨 @Silke_Gillessen @AOmlin @weoncologists
QME
@adamsgerard73 @CMichaelGibson But can it identify a horse in a series of pictures? That’s the real test I believe.
English
@Prof_IanD @CMichaelGibson If it can answer one question it’s definitely in the 99.99th percentile
English
@minncoma @JannyWurts Imagine starting to read a sweeping epic fantasy and knowing it has an actual ending.
@Mark__Lawrence said once he doesn’t publish the first book in a trilogy until all three are written.
English
@JannyWurts Oh now I’m both excited and terrified 😭 I’m a new fan; your storytelling is honestly phenomenal, and the way you weave everything together is incredible!
English
@AlisonBirtle @OpenMedicineHQ Rash occurs with all the lutamides (apa, enza, daro) but some patients will have it with one and not another. I just wanted to point out that there was an option missing!
English
@Prof_IanD @OpenMedicineHQ Ive done that twice in 2 years as if you proactively manage usually not an issue.
English
Here is my Treatment algorithm for Early Identification and Management of Patients with Rash on Apalutamide on @OpenMedicineHQ. Interactive, evidence-linked, open for discussion. Feedback welcome. #LivingAlgorithms
myopenmedicine.com/algorithms/ear…
English
Trump says his "ballroom" will feature a drone port, thick bulletproof glass, and bulletproof walls
English
Neeraj Agarwal, MD, FASCO@neerajaiims
Ab#5001 @ASCO #ASCO26 by @ChrisSweens1👉 bit.ly/4dnFUvD👉Decipher Prostate Genomic Classifier (DGC) predicts benefit w/ triplet Rx in #prostatecancer👉DGC>0.85 is predictive of benefit from adding docetaxel to ADT+Enza👇@Prof_IanD @OncoAlert @urotoday @PCF_science
QME
'Angry' might be a bit too far, but probably 'ough.'
rough
cough
drought
though
thought
through
ຸ@omolxlu
weirdest thing that gets you angry?
English
@LiangRhea We feel that way about Australian doctors in USA, can't understand a damn word. Crikey!😬
English
I'm indignant on behalf of UK immigrant doctors, who make up nearly 20% of 'overseas doctors' in Australia, and generally speak VERY good English.
amante2@AmeliaBee7
This should be plastered on every hospital Emergency room across Australia After all, aspiring PM Hanson has publicly insisted that she’s “a woman of her word” #NoWonderNaziesLoveON
English
GIF
English
Finalizing my PROTEUS Discussant talk for #ASCO26 Plenary. Biggest trial of surgery for prostate cancer, so much data, so many fascinating angles to consider. Will be big moment for Rx of high-risk prostate cancer. Look forward to Dr Taplin reading it out @DanaFarber_GU @gu_onc
Melbourne, Victoria 🇦🇺 English
@ASCO Thanks. This happens pretty much every year though, and it’s usually waiting for me when I return to work after the meeting. I could understand it happening once but this is clearly a systemic issue.
English
@Prof_IanD Hello! Badges were sent out in early April. We sincerely apologize that yours has not arrived yet or has been delayed in transit. We will have a reprint waiting for you at ASCO HQ (Room N427b) so you don't have to go to registration when you arrive.
English
@RKSayyid @urotoday I was not there for the presentation. Were these populations comparable? Patient or other factors may have affected treatment choice and outcomes. We observed this in @ANZUPtrials #ENZAMET for example.
English
mHSPC: 🇺🇸 Real-world treatment patterns in community urology practices (PRECISION)
n=34,882
Initial treatment (first 4 mos):
🔹ADT alone: 50.6%
🔹Doublet: 47.8%
🔹Triplet: 1.6%
Among pts starting ADT alone, 79% never underwent intensification with ARPI and/or docetaxel
3-year CRFS:
🔹ADT alone: 48.6%
🔹Doublet: 55.7%
🔹Triplet: 63.1%
3-year OS:
🔹ADT alone: 73.9%
🔹Doublet: 74.5%
🔹Triplet: 84.4%
@urotoday
#AUA26
English
Ian Davis (Bluesky @profiand) retweetledi
[The Enterprise on Zoom and PowerPoint]
Data: We’re being hailed
Picard: On screen
D: Can you see that?
P: Put it on slide show
D: But then I can’t see Helm or Weapons
P: You’re on preview, you need to swap views
D: I know, I... just a second...
Romulan: You’re on mute
English